HIGH-GRADE SEROUS OVARIAN CANCER
Clinical trials for HIGH-GRADE SEROUS OVARIAN CANCER explained in plain language.
Never miss a new study
Get alerted when new HIGH-GRADE SEROUS OVARIAN CANCER trials appear
Sign up with your email to follow new studies for HIGH-GRADE SEROUS OVARIAN CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New Two-Drug pill combo targets tough gynecologic cancers
Disease control Recruiting nowThis study is testing whether taking two oral drugs, VS-6766 and defactinib, together can help control recurrent gynecologic cancers like ovarian and cervical cancer. It is for women whose cancer has a specific genetic change and has come back or worsened after at least one prior…
Matched conditions: HIGH-GRADE SEROUS OVARIAN CANCER
Phase: PHASE2 • Sponsor: University of Oklahoma • Aim: Disease control
Last updated Mar 27, 2026 12:39 UTC
-
First patients receive experimental drug in global cancer trial
Disease control Recruiting nowThis is the first study in people to test the safety and behavior of a new drug called azirkitug. It will be given alone and in combination with two other cancer drugs to adults with advanced solid tumors, including lung and head and neck cancers, who have already tried standard …
Matched conditions: HIGH-GRADE SEROUS OVARIAN CANCER
Phase: PHASE1 • Sponsor: AbbVie • Aim: Disease control
Last updated Mar 27, 2026 12:37 UTC
-
New targeted drug trial offers hope for Tough-to-Treat cancers
Disease control Recruiting nowThis study is testing a new drug called Rina-S in people whose solid tumor cancers have spread or cannot be removed by surgery. The main goals are to find a safe dose and see if the drug can shrink tumors. It is for people with several types of advanced cancer, including ovarian,…
Matched conditions: HIGH-GRADE SEROUS OVARIAN CANCER
Phase: PHASE1, PHASE2 • Sponsor: Genmab • Aim: Disease control
Last updated Mar 12, 2026 13:51 UTC
-
Virus therapy trial offers new hope for tough ovarian cancers
Disease control Recruiting nowThis study is testing if a modified virus called Olvi-Vec, given directly into the abdomen, can help chemotherapy work better for women with ovarian cancer that has stopped responding to standard platinum drugs. Participants will be randomly assigned to receive either the virus f…
Matched conditions: HIGH-GRADE SEROUS OVARIAN CANCER
Phase: PHASE3 • Sponsor: Genelux Corporation • Aim: Disease control
Last updated Mar 04, 2026 15:30 UTC